Docket HopperPart I · Bills · 119th H.R. 1060
H.R. 1060 · 119th CongressHealth

Modern Authentication of Pharmaceuticals Act of 2025 has not moved since its introduction on Feb 6, 2025, with cosponsors, all Republicans

Sponsored by Davis, Donald G. D-NC · 3 cosponsors: 0 Democrats, 3 Republicans
IntroducedFeb 6, 2025
Reported—
Passed one chamber—
Passed both—
Law—
What it changes · CRS summary

Written by the Congressional Research Service [2]. 99 words.

Modern Authentication of Pharmaceuticals Act of 2025 This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable. The bill applies to products manufactured beginning five years after the bill's enactment.

Context
Committees
House Energy and Commerce Committee
Policy area
Health: 122 of 9,357 bills became law, 113th–118th (1.3%)
Sponsor
1 of 52 bills enacted since 2013
Text versions
1: introduced in house · 363 words
Subjects
Drug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesPrescription drugsSupply chain
Latest action
Feb 6, 2025: Referred to the House Committee on Energy and Commerce.
Records
Congress.gov · Bill text
Exhibit 1Passage odds band at each stage, rated when the bill reached it [4]
Related bills · 0

The bill status record lists no related bills.

Exhibit 2Articles naming the bill per day, last 90 days, US sources [3]